Moderna（MRNA）今日盘中大涨5%，延续了近期强劲的上涨势头。
消息面上，Moderna近期从全球联盟获得5430万美元资金，用于支持其实验性禽流感疫苗的后期开发。此外，公司于11月20日宣布从Ares Management Credit Funds获得15亿美元的五年期定期贷款融资，并设定了明年10%的收入增长目标。这些资金注入和增长预期增强了投资者信心。
另据报导，美国食品药品管理局（FDA）高级官员表示，暂无计划在新冠疫苗上添加"黑框"警告，消除了部分监管风险。尽管近期股价上涨缺乏明确的新催化剂，但市场对Moderna的疫苗管线进展和财务健康状况持续看好。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.